About Fresenius SE & Co. KGaA (FRE)
Fresenius SE & Co. KGaA is a Medical Care Facilities company operating in the Healthcare sector. The company is headquartered in Bad Homburg vor der Höhe, Germany. FRE has been publicly traded since 1998, giving it 28+ years of trading history.
Fresenius SE & Co. KGaA (FRE) has been publicly traded since 1998, making it a 28-year-old public company. It operates in the Medical Care Facilities industry within the Healthcare sector. The company is headquartered in Bad Homburg vor der Höhe, Germany and employs approximately 176,486 people. With a market capitalization of €26 billion, FRE is a large established company.
FRE trades on the German stock exchanges (XETRA/Frankfurt) and is classified as a large-cap-cap stock with a market capitalization of approximately €26 billion. The company employs approximately 176,486 people worldwide.
Key Statistics
- Current Price
- €46.82
- Market Cap
- €26.37B
- 52-Week High
- €52.96
- 52-Week Low
- €31.60
- Sector
- Healthcare
- Industry
- Medical Care Facilities
FRE Investment Performance
FRE has declined 4.4% year-to-date in 2026. Over the past 5 years, a €1,000 investment in FRE would have grown to €1,371, representing a 37.1% total return. Since its IPO in 1998, a €1,000 investment would now be worth €3,378.
€1,000 Invested in Fresenius SE & Co. KGaA (FRE)
How much would €1,000 invested in FRE be worth today?
What would €1,000 invested in FRE 1 year ago be worth today?
A €1,000 investment in Fresenius SE & Co. KGaA (FRE) in 2025 would be worth €1,217 as of March 2026, representing a +21.7% total return.
What would €1,000 invested in FRE 3 years ago be worth today?
A €1,000 investment in Fresenius SE & Co. KGaA (FRE) in 2023 would be worth €1,995 as of March 2026, representing a +99.5% total return.
What would €1,000 invested in FRE 5 years ago be worth today?
A €1,000 investment in Fresenius SE & Co. KGaA (FRE) in 2021 would be worth €1,371 as of March 2026, representing a +37.1% total return.
What would €1,000 invested in FRE 10 years ago be worth today?
A €1,000 investment in Fresenius SE & Co. KGaA (FRE) in 2016 would be worth €866 as of March 2026, representing a -13.4% total return.
What would €1,000 invested in FRE at IPO be worth today?
A €1,000 investment in Fresenius SE & Co. KGaA (FRE) at IPO would be worth €3,378 as of March 2026, representing a +237.8% total return.
Monthly Returns Heatmap
Over the past 27+ years (328 months), Fresenius SE & Co. KGaA (FRE) has averaged a monthly return of +0.81% with a median return of +0.81%. The stock had 180 positive months (55%) and 148 negative months (45%). The best month in FRE's history was October 2002 with a +59.6% return, while the worst was June 2001 at -42.1%. Historically, November tends to be the strongest month (averaging +3.9%), and June the weakest (-2.8%).
FRE's longest winning streak was 9 consecutive months of gains, while its longest losing streak was 6 consecutive months of losses. The best full year was 2003 with a cumulative return of +69.8%, and the worst was 2001 at -77.6%.
Annual Returns
Over 28 years of trading history, Fresenius SE & Co. KGaA (FRE) has delivered an average annual return of +10.31% with a median return of +14.40%. The compound annual growth rate (CAGR) is +4.26%. The stock posted gains in 18 years (64%) and losses in 10 years (36%).
FRE's best year was 2003 with a +93.56% gain, while the worst was 2001 at -61.46%. The longest streak of consecutive positive years was 8, and the longest losing streak was 3 years. FRE achieved double-digit gains (10%+) in 17 years. It suffered double-digit losses in 7 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -4.41% | €48.98 | €46.82 |
| 2025 | +49.77% | €32.70 | €48.98 |
| 2024 | +19.27% | €27.42 | €32.70 |
| 2023 | +10.58% | €24.80 | €27.42 |
| 2022 | -23.60% | €32.45 | €24.80 |
| 2021 | -4.64% | €34.03 | €32.45 |
| 2020 | -22.95% | €44.17 | €34.03 |
| 2019 | +20.38% | €36.69 | €44.17 |
| 2018 | -34.16% | €55.73 | €36.69 |
| 2017 | -11.69% | €63.10 | €55.73 |
| 2016 | +13.54% | €55.57 | €63.10 |
| 2015 | +52.85% | €36.36 | €55.57 |
| 2014 | +17.34% | €30.99 | €36.36 |
| 2013 | +29.61% | €23.91 | €30.99 |
| 2012 | +23.36% | €19.38 | €23.91 |
| 2011 | +15.27% | €16.81 | €19.38 |
| 2010 | +46.56% | €11.47 | €16.81 |
| 2009 | +22.43% | €9.37 | €11.47 |
| 2008 | -34.58% | €14.32 | €9.37 |
| 2007 | +11.79% | €12.81 | €14.32 |
| 2006 | +48.10% | €8.65 | €12.81 |
| 2005 | +48.87% | €5.81 | €8.65 |
| 2004 | +21.98% | €4.76 | €5.81 |
| 2003 | +93.56% | €2.46 | €4.76 |
| 2002 | -53.33% | €5.27 | €2.46 |
| 2001 | -61.46% | €13.69 | €5.27 |
| 2000 | +3.41% | €13.24 | €13.69 |
| 1999 | -9.15% | €14.57 | €13.24 |
FRE Investment Analysis: Valuation, Risk & Dividends
Key factors to consider when evaluating Fresenius SE & Co. KGaA as an investment
Valuation
FRE currently trades at a trailing P/E ratio of 22.8, which is considered moderate relative to the broader market. The forward P/E of 11.7 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 1.4. The price-to-sales ratio is 1.2.
Dividends
Fresenius SE & Co. KGaA pays a dividend to shareholders with a current yield of 2.24%. This translates to €1.05 per share annually. The payout ratio of 49% indicates sustainable dividend coverage.
Risk & Volatility
FRE has a beta of 0.91, indicating it is similarly volatile to the overall market. The stock's 52-week range is €31.60 to €52.96, and it currently trades in the upper half of its 52-week range.
Analyst Ratings
Based on 14 analyst opinions, FRE has a consensus "buy" rating. The average price target of €55.90 suggests 19.4% upside from current levels.
Frequently Asked Questions: FRE
What sector is FRE in? ▼
FRE operates in the Healthcare sector, specifically in the Medical Care Facilities industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has FRE performed historically? ▼
Over 28 years of trading history, FRE has posted gains in 18 years (64% of the time). The best year was 2003 with a +93.6% return. Past performance does not guarantee future results.
How can I invest in FRE? ▼
You can invest in FRE through any brokerage account that offers access to German exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold FRE.
Does FRE pay dividends? ▼
Fresenius SE & Co. KGaA pays a dividend to shareholders with a current yield of 2.24%. This translates to €1.05 per share annually. The payout ratio of 49% indicates sustainable dividend coverage.
What does Fresenius SE & Co. KGaA do? ▼
Fresenius SE & Co. KGaA is a Medical Care Facilities company operating in the Healthcare sector. The company is headquartered in Bad Homburg vor der Höhe, Germany.
What sector is FRE in? ▼
FRE operates in the Healthcare sector, specifically in the Medical Care Facilities industry.
When did FRE go public? ▼
Fresenius SE & Co. KGaA went public in 1998, making it a 28-year-old public company as of 2026.
How much would €1,000 invested in FRE 5 years ago be worth today? ▼
A €1,000 investment in FRE five years ago would be worth approximately €1,371 today, representing a 37.1% return.
How much would €1,000 invested in FRE 10 years ago be worth today? ▼
A €1,000 investment in FRE ten years ago would be worth approximately €866 today, representing a -13.4% total return over the decade.
What is FRE's 3-year return? ▼
Over the past 3 years, FRE has returned 99.5%. A €1,000 investment would have grown to €1,994.
How much would €1,000 invested in FRE at IPO be worth today? ▼
If you invested €1,000 in FRE at its IPO in 1998, it would be worth approximately €3,378 today, a 237.8% return over 28 years.
Does FRE pay dividends? ▼
Yes, Fresenius SE & Co. KGaA pays a dividend with a current yield of 2.24%, which is €1.05 per share annually.
What is FRE's market cap? ▼
Fresenius SE & Co. KGaA has a market capitalization of €26 billion, classifying it as a large-cap company.
What is FRE's P/E ratio? ▼
FRE has a trailing P/E ratio of 22.8 and a forward P/E of 11.7, which measures how much investors are paying per dollar of earnings.
Is FRE a buy, hold, or sell? ▼
Based on 14 opinions, FRE has a consensus "buy" rating. The average price target is €55.9.
Last updated: 3/15/2026